JFEYF yields 3.29% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, JFEYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JFEYF + PFE for your $10,000?
JFE Systems, Inc. provides information systems integration, operation, and maintenance services in Japan. The company provides business systems integration services, including planning and consulting for information systems; design, development, and implementation of building information systems; operating, maintaining, and providing outsourcing services; and enhancing information systems. It also offers product-based solutions, such as building ERP/SCM/production planning systems, BI systems, cost management systems, procurement systems, electronic documentation systems, and quality information management and recipe management systems for the food industry, as well as various packaged software solutions. In addition, the company provides infrastructure/cloud computing solutions, which includes SaaS, PaaS, and IaaS; and system coordination and migration solutions. It serves finance, food products, logistics, automotive, and other manufacturing industries. JFE Systems, Inc. was formerly known as Kawasaki Steel Systems R&D Corporation and changed its name to JFE Systems, Inc. in 2004. The company was founded in 1983 and is headquartered in Tokyo, Japan. JFE Systems, Inc. is a subsidiary of JFE Steel Corporation.
Full JFEYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.